ImportRefusal LogoImportRefusal

Compania Farmaceutica

⚠️ Moderate Risk

FEI: 3012141197 • Tegucigalpa, Francisco Morazan • HONDURAS

FEI

FEI Number

3012141197

📍

Location

Tegucigalpa, Francisco Morazan

🇭🇳

Country

HONDURAS
🏢

Address

Colonia Tiloarque Blvd De Las Frerzas, , Tegucigalpa, Francisco Morazan, Honduras

Moderate Risk

FDA Import Risk Assessment

33.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
5
Unique Violations
5/9/2022
Latest Refusal
4/21/2022
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
17.7×30%
Recency
11.2×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
5/9/2022
62GBC49NAPROXEN (ANTI-INFLAMMATORY)
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/21/2022
62GAL18DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
118NOT LISTED
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Compania Farmaceutica's FDA import refusal history?

Compania Farmaceutica (FEI: 3012141197) has 2 FDA import refusal record(s) in our database, spanning from 4/21/2022 to 5/9/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Compania Farmaceutica's FEI number is 3012141197.

What types of violations has Compania Farmaceutica received?

Compania Farmaceutica has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Compania Farmaceutica come from?

All FDA import refusal data for Compania Farmaceutica is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.